PPD DEVELOPMENT LP - DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX)

PIID: 75N93026F00001Solicitation ID: 75N93025R00010

Signed Date: Dec 10, 2025Effective Date: Dec 15, 2025End Date: Closes in 55 days

Award $

$3.1M

Vendor

PPD DEVELOPMENT LP

NAICS

541714

Signed Date

Dec 10, 2025

Key Details

Dollars Obligated

$3.1M

Base & All Options

$21.6M

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

National Institutes of Health

NAICS Code

541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)

Product Service Code

AN42 - HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Place of Performance

WILMINGTON, NC, 284013331, CD-NC-07

Description

DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX)

Context & Analysis

On Dec 10, 2025, Department of Health and Human Services obligated $3,092,829 to PPD DEVELOPMENT LP for daids monitoring for 1 phase iii study: a5300b/i2003b (phoenix). The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition. Performance is located in WILMINGTON, NC. The contract is scheduled through Dec 14, 2026 — approximately 2 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541714 — related awards are listed below.